Un anno di letteratura nefrologica sulla nefrolitiasi

Coe F.L. , Evan A. , Worcester E. Kidney stone disease. J Clin Invest 2005; 115: 2598–608.

Williams A.W. , Wilson D.M. Dietary intake, absorption, metabolism, and excretion of oxalate. Semin Nephrol 1990; 10: 2–8.

Holmes R.P. , Goodman H.O. , Assimos D.G. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 2001; 59: 270–6.

Allison M.J. , Cook H.M. , Milne D.B. , Gallagher S. , Clayman R.V. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 1986; 116: 455–60.

Massry S.G. , Glassock R.J. , ed. Massry & Glassock's Textbook of Nephrology (4th edition), Philadelphia: Lippincott Williams & Wilkins, 2001; 308–40.

Silverberg S.J. The distribution and balance of calcium, magnesium and phosphorus. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Kelseyville (CA): The American Society for Bone and Mineral Research, 1990; 30–2.

Yamamoto T. , Moriwaki Y. , Takahashi S. Effect of ethanol on metabolism of purine bases (hyoxanthine, xanthine, and uric acid). Clin Chim Acta 2005; 356: 35–57.

Maesaka J.K. , Fishbane S. Regulation of renal urate excretion: a critical review. Am J Kidney Dis 1999; 32: 917–33.

West B. , Luke A. , Durazo-Arvizu R.A. , Cao G. , Shoham D. , Kramer H. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis 2008; 51(5): 741–7.

Sakhaee K. , Maalouf N.M. , Metabolic syndrome and uric Acid nephrolithiasis. Semin Nephrol 2008; 28(2 La nefrolitiasi nel terzo millennio: una patologia di pe): 174–80.

Daudon M. , Jungers P. Diabetes and nephrolithiasis. Curr Diab Rep 2007; 7(6): 443–8.

Lee S.C. , Kim Y.J. , Kim T.H. , Yun S.J. , Lee N.K. , Kim W.J. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol 2008; 179(2 La nefrolitiasi nel terzo millennio: una patologia di pe): 403–4.

Duffey B.G. , Pedro R.N. , Kriedberg C. . Lithogenic risk factors in the morbidly obese population. J Urol 2008; 179(4): 1401–6.

Duffey B.G. , Pedro R.N. , Makhlouf A. . Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis. J Am Coll Surg 2008; 206(3): 1145–53.

Lieske J.C. , Kumar R. , Collazo-Clavell M.L. Nephrolithiasis After Bariatric Surgery for Obesity. Semin Nephrol 2008; 28(2 La nefrolitiasi nel terzo millennio: una patologia di pe): 163–73.

Asplin J.R. , Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol 2007; 177(2 La nefrolitiasi nel terzo millennio: una patologia di pe): 565–9.

Sinha M.K. , Collazo-Clavell M.L. , Rule A. , Milliner D.S. , Nelson W. , Sarr M.G. , Kumar R. , Lieske J.C. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 2007; 72(1): 8–10.

Kleinman J.G. Bariatric surgery, hyperoxaluria, and nephrolithiasis: a plea for close postoperative management of risk factors. Kidney Int 2007; 72(1): 100–7.

Nasr S.H. , D'Agati V.D. , Said S.M. , Stokes M.B. , Largoza M.V. , Radhakrishnan J. , Markowitz G.S. Oxalate Nephropathy Complicating Roux-en-Y Gastric Bypass: An Underrecognized Cause of Irreversible Renal Failure. Clin J Am Soc Nephrol 2008 Aug 13.

Cirillo M. , Iudici M. , Marcarelli F. , Laudato M. , Zincone F. , La nefrolitiasi nelle patologie intestinali, Giornale italiano di nefrologia/ n no 25 N. 1, 2008: 42–48

Ciacci C. , Spagnuolo G. , Tortora R. , Bucci C. , Franzese D. , Zingone F. , Cirillo M. Urinary stone disease in adults with celiac disease: prevalence, incidence and urinary determinants. J Urol 2008; 180(3): 974–9.

Sarica K. , Akarsu E. , Erturhan S. , Yagci F. , Aktaran S. , Altay B. Evaluation of urinary oxalate levels in patients receiving gastrointestinal lipase inhibitor. Obesity (Silver Spring) 2008; 16(7): 1579–84.

Asselman M. , Verkoelen C.F. Fructose intake as a risk factor for kidney stone disease. Kidney Int 2008; 73(2 La nefrolitiasi nel terzo millennio: una patologia di pe): 207–12.

Taylor E.N. , Curhan G.C. Fructose consumption and the risk of kidney stones. Kidney Int. 2008; 73(2 La nefrolitiasi nel terzo millennio: una patologia di pe): 139–40.

Esposito L. , Rostaing L. , Gennero I. , Mehrenberger M. , Durand D. , Kamar N. Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient. J Urol 2007; 177(4): 1358–62.

Escobar C. , Byer K.J. , Khaskheli H. , Khan S.R. Apatite induced renal epithelial injury: insight into the pathogenesis of kidney stones. J Urol 2008; 180(1): 379–87.

Warner B.W. , LaGrange C.A. , Tucker T. , Bensalem-Owen M. , Pais V.M. Jr. . Induction of progressive profound hypocitraturia with increasing doses of topiramate. Urology 2008; 72(1): 29–32.

Penniston K.L. , Steele T.H. , Nakada S.Y. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation. Urology 2007; 70(5): 856–60.

Haleblian G.E. , Leitao V.A. , Pierre S.A. , Robinson M.R. , Albala D.M. , Ribeiro A.A. , Preminger G.M. Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis. J Endourol 2008; 22(6): 1359–66.

Kang D.E. , Sur R.L. , Haleblian G.E. , Fitzsimons N.J. , Borawski K.M. , Preminger G.M. , Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol 2007; 177(4): 1358–62.

Tosukhowong P. , Yachantha C. , Sasivongsbhakdi T. , Ratchanon S. , Chaisawasdi S. , Boonla C. , Tungsanga K. Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients. Urol Res 2008; 36(3-4): 149–55.

Grujic D. , Salido E.C. , Shenoy B.C. , Langman C.B. , McGrath M.E. , Patel R.J. , Rashid A. , Mandapati S. , Jung C.W. , Margolin A.L. Hyperoxaluria Is Reduced and Nephrocalcinosis Prevented with an Oxalate-Degrading Enzyme in Mice with Hyperoxaluria. Am J Nephrol 2008; 12: 29(2 La nefrolitiasi nel terzo millennio: una patologia di pe): 86–93.

Lieske J.C. , Regnier C. , Dillon J.J. Use of sevelamer hydrochloride as an oxalate binder. J Urol 2008; 179(4): 1407–10.

Kemal Sarica · Sakip Erturhan · Bulent Altay. Effect of verapamil on urinary stone-forming risk factors. Urol Res (2007) 35: 23–27.

Segura Torre P. , Borrego Utiel F.J. , Pérez Del Barrio P. , Gil Cunqueiro J.M. , Pérez Ba-asco V. Efficacy of Rasburicase therapy in obstructive nephropathy from renal calculi: a novel therapeutic. Nefrologia 2008; 28(1): 102–05.

Kaufman D.W. , Kelly J.P. , Curhan G.C. , Anderson T.E. , Dretler S.P. , Preminger G.M. , Cave D.R. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 2008; 19(6): 1197–203.